サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566798

接着バリア市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Adhesion Barrier Market By Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
接着バリア市場：タイプ別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

接着バリア市場は2023年に7億米ドルと評価され、2024～2033年にかけてCAGR 7.8％で成長し、2033年には15億米ドルに達すると予測されています。

接着バリアは、手術中の接着形成リスクを軽減する医療用インプラントです。接着は、手術後に起こりうる組織や臓器間の異常な結合です。接着に関連するその他の合併症には、腸閉塞、不妊症、慢性疼痛などがあり、治癒中に組織同士が接着することで生じることがあります。接着を防ぐために、接着バリアは組織間に一時的なバリアを作る。

世界の接着バリア市場の成長は、手術後の接着リスクの憂慮すべき上昇によってもたらされます。ある調査によると、93％の人が1回以上の腹部手術後に接着を発症しています。さらに、接着に伴う合併症に対する医療従事者の意識の高まりや、革新的な接着バリア製品の開拓が、世界市場の成長に大きく寄与しています。研究者やメーカーは、生体吸収性材料から作られた接着バリアの開発に注力しており、この接着バリアは徐々に体内に吸収されるため、剥離処置の必要性がなくなります。例えば、医療ソリューションの大手プロバイダーの一つであるBaxter Advanced Surgery社は、Seprafilm接着バリアを開発しました。この接着バリアは、2種類の陰イオン性多糖類、変性ヒアルロン酸ナトリウムとカルボキシメチルセルロースで構成された、無菌、生体吸収性、半透明、親水性の接着バリアです。この接着バリアは接着の範囲、発生率、重症度を有意に減少させることができます。ランダム化、前向き、二重盲検、多施設共同臨床研究では、潰瘍性大腸炎と馴染みのあるポリポーシスに罹患し、2段階の腸切除手術を受けた183人の患者を対象としました。このうち、セプラフィルム接着バリア群では51％の患者に接着が認められなかったのに対し、対照群では術後8～12週で6％でした。さらに、接着バリアを含む外科手術に対する償還政策の増加がその使用を促し、世界市場の成長を後押ししています。しかし、現在進行中の調査にもかかわらず、術後の接着を予防するために広く使用されている特定の接着防止バリアは存在せず、これが市場の主要な阻害要因となっています。逆に、医療従事者は接着関連合併症のリスクを最小化するために、接着バリアを手術プロトコールに組み込んでおり、これが世界の需要の原動力になると予想されます。さらに、医療会や医療団体による接着の予防と管理に関する認識を広め、ガイドラインを確立するためのイニシアチブの増加は、予測期間中に世界市場の拡大に有益な機会を提供すると予想されます。

世界の接着バリア市場は、タイプ、用途、エンドユーザー、地域に区分されます。タイプ別では、市場は合成接着バリアと天然接着バリアに分類されます。用途別では、一般/腹部外科、婦人科外科、心臓血管外科、整形外科、神経外科、その他に分類されます。エンドユーザー別では、病院、専門クリニック、外来手術センターに細分化されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析しています。

主要調査結果

  • 製品タイプ別では、合成接着バリアセグメントが2023年のシェアで市場を独占しました。
  • 用途別では、一般/腹部外科手術セグメントが2023年の主要株主でした。
  • エンドユーザー別では、病院セグメントが2023年に最大シェアを獲得しました。
  • 北米が大きなシェアを占めています。

競合情勢

本レポートのカスタマイズが可能です（追加費用とスケジュールが必要です。）

  • 製品/セグメント別市場セグメンテーション
  • 国別または地域別の追加分析-市場規模と予測
  • 平均販売価格分析/価格帯分析
  • 企業プロファイルの拡大リスト
  • 過去の市場データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 接着バリア市場：タイプ別

  • 市場概要
  • 合成接着バリア
  • 天然接着バリア

第5章 接着バリア市場：用途別

  • 市場概要
  • 一般外科/腹部外科
  • 婦人科手術
  • 心臓血管外科
  • 整形外科
  • 神経外科
  • その他

第6章 接着バリア市場：エンドユーザー別

  • 市場概要
  • 病院
  • 専門クリニック
  • 外来手術センター

第7章 接着バリア市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の接着バリア市場
    • カナダの接着バリア市場
    • メキシコの接着バリア市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの接着バリア市場
    • フランスの接着バリア市場
    • 英国の接着バリア市場
    • イタリアの接着バリア市場
    • スペインの接着バリア市場
    • その他の欧州の接着バリア市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本の接着バリア市場
    • 中国の接着バリア市場
    • オーストラリアの接着バリア市場
    • インドの接着バリア市場
    • 韓国の接着バリア市場
    • その他のアジア太平洋の接着バリア市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの接着バリア市場
    • サウジアラビアの接着バリア市場
    • 南アフリカの接着バリア市場
    • その他のラテンアメリカ・中東・アフリカの接着バリア市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Anika Therapeutics Inc.
  • Baxter International Inc.
  • Leader Biomedical
  • Betatech Medical
  • Fziomed, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson And Johnson
  • CGBio Inc
  • Atrium Medical Corporation
  • Toray Industries Inc.
目次
Product Code: A09554

The adhesion barrier market was valued at $0.7 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Adhesion barrier is a medical implant that alleviates the risk of adhesion formation during surgeries. Adhesion is an abnormal connections between tissues or organs that can occur after surgery. Other complications associated with adhesion include bowel obstructions, infertility, and chronic pain, which can arise when tissues stick together while healing. To prevent them from sticking, adhesion barriers create a temporary barrier between the tissues.

The growth of the global adhesion barrier market is driven by alarming rise in the risk of post-surgical adhesions. According to a study, 93% of individuals develop adhesions following one or more abdominal operations. Moreover, increase in awareness among healthcare professionals about the complications associated with adhesions and development of innovative adhesion barrier products notably contribute toward the growth of the global market. Researchers and manufacturers are focusing on the development of adhesion barriers made from bioresorbable materials, which are absorbed by the body gradually, thereby eliminating the need for removal procedures. For instance, Baxter Advanced Surgery, one of the leading providers of healthcare solutions, developed Seprafilm adhesion barrier, which is a sterile, bioresorbable, translucent, and hydrophilic adhesion barrier composed of two anionic polysaccharides, modified sodium hyaluronate and carboxymethylcellulose. This adhesion barrier is capable of significantly reducing the extent, incidence, and severity of adhesions. A randomized, prospective, double-blinded, multicenter clinical study involved 183 patients suffering from ulcerative colitis and familiar polyposis who underwent 2-stage intestinal resection surgery. Among these, 51% of the patients of the Seprafilm Adhesion Barrier group were adhesion-free compared to 6% of control patients post at 8-12 weeks of surgery. Furthermore, increase in reimbursement policies for surgical procedures involving adhesion barriers encourage their use, which boosts the growth of the global market. However, there is no specific adhesion barrier that is widely used to prevent post-surgical adhesions, despite ongoing research, which acts as a key deterrent factor of the market. On the contrary, healthcare professionals are incorporating the use of adhesion barriers into their surgical protocols to minimize the risk of adhesion-related complications, which is expected to drive their demand globally. Moreover, rise in initiatives to spread awareness and establish guidelines regarding the prevention and management of adhesions by medical societies and healthcare organizations is anticipated to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global adhesion barrier market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into synthetic adhesion barrier, and natural adhesion barrier. Depending on application, it is segregated into general/abdominal surgeries, gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, and others. By end user, it is fragmented into hospitals, Specialty Clinics, Ambulatory Surgical Centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • By product type, the synthetic adhesion barrier segment dominated the market, in terms of share in 2023.
  • Depending on application, the general/abdominal surgeries segment was the major shareholder in 2023.
  • On the basis of end user, the hospital segment acquired the maximum share in 2023.
  • North America holds a significant share of the market.

Competitive Landscape

The competitive analysis and profiles of the major players in the global adhesion barrier market include Anika Therapeutics Inc., Baxter International Inc., leader biomedical, Betatech Medical, Fziomed, Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson, CGBio Inc., Atrium Medical Corporation, and Toray Industry Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Synthetic Adhesion Barrier
  • Natural Adhesion Barrier

By Application

  • General/Abdominal Surgeries
  • Gynecological Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Other Applications

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Anika Therapeutics Inc.
    • Baxter International Inc.
    • leader biomedical
    • Betatech Medical
    • fziomed, inc.
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson
    • CGBio Inc
    • Atrium Medical Corporation
    • Toray Industries Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ADHESION BARRIER MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Synthetic Adhesion Barrier
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Natural Adhesion Barrier
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ADHESION BARRIER MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. General/Abdominal Surgeries
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Gynecological Surgeries
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Cardiovascular Surgeries
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Orthopedic Surgeries
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Neurological Surgeries
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Other Applications
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: ADHESION BARRIER MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Ambulatory Surgical Centers
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ADHESION BARRIER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Adhesion Barrier Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Adhesion Barrier Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Adhesion Barrier Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Adhesion Barrier Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Adhesion Barrier Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Adhesion Barrier Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Adhesion Barrier Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Adhesion Barrier Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Adhesion Barrier Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Adhesion Barrier Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Adhesion Barrier Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Adhesion Barrier Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Adhesion Barrier Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Adhesion Barrier Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Adhesion Barrier Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Adhesion Barrier Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Adhesion Barrier Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Adhesion Barrier Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Adhesion Barrier Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Anika Therapeutics Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Baxter International Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Leader Biomedical
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Betatech Medical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Fziomed, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Integra LifeSciences Holdings Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Johnson And Johnson
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. CGBio Inc
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Atrium Medical Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Toray Industries Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments